22. Lipoprotein(a) reduction by N-acetylcysteine.Gavish, Dov and Breslow, Jan L.The Lancet 337:203-4 (Jan. 26, 1991)

23. N-acetylcysteine and lipoprotein.Stalenhoef, A. F. H., et al,The Lancet 337:491 (Feb. 23, 1991)

24. N-Acetylcysteine and immunoreactivity of lipoprotein(a).Scanu, Angelo M.The Lancet 337:1159 (May 4, 1991)

25. Thiols and cysteine-containing compounds attenuate theimmunoreactivity of Lp(a).Scanu, Angelo M., et al,Arterioscl. Thromb. 11(5):1481a (Sep./Oct. 1991)

26. The role of glutathione status in the protection againstischaemic and reperfusion damage: Effects ofN-acetylcysteine.Ceconi, C., et al,J. Mol. Cell Cardiol. 20:5-13 (1988)

27. Beneficial effects of N-acetylcysteine and cysteine instunned myocardium in perfused rat heart.Tang, L-D., et al,Brit. J. Pharmacol. 102(3):601-6 (1991)

28. Lipoprotein(a) reduction by N-acetylcysteine.Hansen, P. R.Lancet 337:672-3 (1991)

29. Continuous oral N-acetylcysteine treatment and developmentof nitrate tolerance in patients with stable anginapectoris.Boesgaard, Soren, et al,J. Cardiovas. Pharmacol. 17(6):889-93 (1991)

30. Mercaptoethanol and N-acetylcysteine enhance T-cell colonyformation in AIDS and ARC.Wu, J., Levy, E. M. and Black, P. H.Clin. Exp. Immunol. 77:7-10 (1989)

31. Lymphocyte dysfunction after DNA damage by toxic oxygenspecies.Carson, D. A., Seto, S. and Wasson, D. B.J. Exp. Med. 163:746-51 (1986)

32. Immunomodulation by neutrophil myeloperoxidase and hydrogenperoxide: Differential susceptibility of human lymphocytefunctions.El-Hag, A., et al,J. Immunol. 136:3420-6 (1986)

33. Thiol-containing antioxidant drugs and the human immunesystem.Stagnaro, R., et al,Bull. Eur. Physiopathol. Respir. 23:303-7 (1987)

34. Suppression of Cytokine-induced Human Immunodeficiency Virus(HIV) expression by N-acetylcysteine (NAC), glutathione(GSH) and Glutathione monoester (GSE)Kinter, Audrey L., et al,75th Annual Meeting of the Federation of American Societiesfor Experimental Biology, Atlanta, Georgia (April 21-5, 1991)J. FASEB 5(5) A1265 (1991)

35. Suppression of human immunodeficiency virus expression inchronically infected monocytic cells by glutathione,glutathione ester, and N-acetylcysteine. Kalebic, Thea, et al,Proc. Natl. Acad. Sci. 88(3):986-90 (1991)

36. Thiol-based compounds may limit AIDS progression.CDC AIDS Weekly p3 (Feb. 25, 1991)

37. N-acetylcysteine inhibits latent HIV expression inchronically infected cells.Roederer, M., et al,AIDS Res. Hum. Retroviruses 7(6):563-7 (1991)

38. Cytokine-stimulated human immunodeficiency virus replicationis inhibited by N-acetylcysteine.Roederer, M., et al,Proc. Natl. Acad. Sci. 87:4884-8 (1990)

39. Intercellular thiols regulate activation of nuclear factorkappa B and transcription of HIV.Staal, F. J., Roederer, M. Herzenberg, L. A. andHerzenberg, L. A.Proc. Natl. Acad. Sci. 87(24):9943-7 (Dec. 1990)

40. Reducing agents and AIDS - Why are we waiting?Turner, V. F.Med. J. Aust. 153/8, 502 (1990)

41. Mercaptoethanol and N-acetylcysteine enhance T-cell colonyformation in AIDS and ARC. Wu, J., et al,Clin. Exp. Immunol. 77/1, 7-10 (1989)